What is BPC-157?
BPC-157 is a 15-amino-acid peptide fragment isolated from a protein present in human gastric juice. It is known for its stability and biological activity in vitro and in vivo studies. This peptide is being widely investigated for its healing, anti-inflammatory, and organ-protective effects. It does not exhibit hormonal activity, making it suitable for focused cellular and tissue regeneration research, and it has gained interest in experimental medicine, especially in the fields of orthopedics, neurology, and gastroenterology.
New Update: In July 2026, an FDA advisory committee narrowly voted to recommend BPC-157 for the 503A compounding list. It has not been added to that list or approved for human use, and further rulemaking would be required. BPC-157 is sold for research use only.
Structure
Chemical Formula: C62H98N16O22
BPC-157 is a pentadecapeptide with a stable structure that remains bioactive in various environments. It is a partial sequence of a naturally occurring protein secreted in the stomach lining, engineered for enhanced stability in laboratory research.
BPC-157 Research
Wound Healing
BPC-157 has been extensively studied for its ability to promote rapid wound healing. It enhances angiogenesis, fibroblast migration, and tissue granulation, all of which are critical for effective tissue regeneration. Animal models have demonstrated accelerated healing of skin, muscle, and connective tissue injuries following administration. Its mechanisms appear to involve modulation of growth factors and cytokines essential for cellular repair.
Vascular Growth and Collateralization
Studies indicate that the peptide supports the formation of new blood vessels (angiogenesis) and may promote collateral circulation following vascular injury. It has been observed to restore blood flow and improve healing in ischemic conditions, likely through the upregulation of VEGF and nitric oxide pathways. These vascular-regenerative effects are currently being explored in models of cardiovascular injury and stroke.
Tendon Healing
In tendon injury models, it has shown promise in accelerating recovery without scar tissue formation. It promotes tenocyte proliferation, collagen organization, and reduces inflammatory markers. Unlike conventional treatments that may impair tendon structure, it supports natural biomechanical function, making it a peptide of interest in orthopedic and sports medicine research.
Antioxidant Properties
BPC-157 exhibits antioxidant activity by reducing oxidative stress markers and supporting mitochondrial integrity. It has been shown to protect tissues from reactive oxygen species (ROS) and lipid peroxidation, particularly in models of liver toxicity and central nervous system injury. These findings suggest it could be valuable in research exploring cellular defense and longevity.
Protection Against Drug Side Effects
The peptide has been studied for its ability to counteract the toxic effects of NSAIDs, corticosteroids, and even certain neuroleptics. It has shown protective effects on the gastrointestinal tract, liver, pancreas, and kidneys in animal models. This makes it highly relevant in studies investigating peptide-based mitigation strategies for drug-induced organ damage.
Effects in Honeybees
A novel area of research includes studies on its effects in honeybee populations exposed to toxic substances. Preliminary data suggests it may improve bee vitality and reduce mortality linked to environmental stressors and pesticides. These results have sparked interest in ecological and agricultural research involving pollinator health and environmental toxicity.
Future Research Directions
BPC-157 continues to be a focus of research into regenerative medicine, neuroprotection, and chronic disease management. Future directions include its application in spinal cord injury, inflammatory bowel disease, mental health disorders, and systemic organ protection. Its wide-reaching therapeutic potential, combined with minimal observed toxicity in animal models, positions it as a highly promising peptide for ongoing and future clinical research.
Reconstitution and dosing
BPC-157 is typically reconstituted with Bacteriostatic water at 5 to 10mg per ml. Standard dosing is 250mcg twice per day up to 1000mcg twice per day for acute injuries. In wellness cycles, it is used in an 8 week on, 8 week off schedule.
For our free Peptide Calculator, CLICK HERE. Research-grade BPC-157 is available from WellnessPeptides.
Disclaimer
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
